Multimodal fundus imaging in Best vitelliform macular dystrophy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 10, 2010, Pages 1377-1386

  Ferrara, Daniela C ^a,b   Costa, Rogério A ^a,b,c   Tsang, Stephen ^d   Calucci, Daniela ^b,c   Jorge, Rodrigo ^a   Freund, K Bailey ^e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital de Olhos de Araraquara   (Brazil)

^c Division of Macula Imaging and Treatment   (Brazil)

^d Howard Hughes Medical Institute   (United States)

^e VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Best disease; Fourier domain; Fundus autofluorescence; Infrared; Optical coherence; Retinal pigment epithelium; Spectral; Tomography; Vitelliform macular dystrophy

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; BEST VITELLIFORM MACULAR DYSTROPHY; BRUCH MEMBRANE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HYPOPYON; MALE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOHYPOPYON; RETINA MACULA VITELLIFORM DEGENERATION; VISUAL ACUITY; AGED; DIAGNOSTIC USE; FLUORESCENCE ANGIOGRAPHY; FOURIER ANALYSIS; GENETICS; MIDDLE AGED; PATHOLOGY; PHOTORECEPTOR CELL; RETINAL DEGENERATION; YOUNG ADULT;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; FLUORESCEIN ANGIOGRAPHY; FOURIER ANALYSIS; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

COLORING AGENT; INDOCYANINE GREEN;

EID: 77956188694     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1381-2     Document Type: Article

References (57)

1. WF Maloney DM Robertson SM Duboff 1977 Hereditary vitelliform macular degeneration: variable fundus findings within a single pedigree Arch Ophthalmol 95 979 983 869756
2. Gass JDM (1997) Stereoscopic atlas of macular diseases, diagnosis and treatment. Mosby, St. Louis
3. EM Stone BE Nichols LM Streb AE Kimura VC Sheffield 1992 Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13 Nat Genet 1 246 250 10.1038/ng0792-246 1302019
4. K Petrukhin MJ Koisti B Bakall W Li G Xie T Marknell O Sandgren K Forsman G Holmgren S Andreasson M Vujic AAB Bergen V McGarty-Dugan D Figueroa CP Austin ML Metzker CT Caskey C Wadelius 1998 Identification of the gene responsible for Best macular dystrophy Nat Genet 19 241 247 10.1038/915 9662395
5. A Marquardt H Stohr LA Passmore F Kramer A Rivera BH Weber 1998 Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best disease) Hum Mol Genet 7 1517 1525 10.1093/hmg/7.9.1517 9700209
6. AD Marmorstein LY Marmorstein M Rayborn X Wang JG Hollyfield K Petrukhin 2000 Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium Proc Natl Acad Sci USA 97 12758 12763 10.1073/pnas.220402097 11050159
7. B Bakall P McLaughlin JB Stanton Y Zhang HC Hartzell LY Marmorstein AD Marmorstein 2008 Bestrophin-2 is involved in the generation of intraocular pressure Invest Ophthalmol Vis Sci 49 1563 1570 10.1167/iovs.07-1338 18385076
8. K Yu Z Qu Y Cui HC Hartzell 2007 Chloride channel activity of bestrophin mutants associated with mild or late-onset macular degeneration Invest Ophthalmol Vis Sci 48 4694 4705 10.1167/iovs.07-0301 17898294
9. CJF Boon BJ Klevering BP Leroy CB Hoyng JEE Keunen AI den Hollander 2009 The spectrum of ocular phenotypes caused by mutations in the BEST1 gene Prog Retin Eye Res 28 187 205 10.1016/j.preteyeres.2009.04.002 19375515
10. T Tsunenari H Sun J Williams H Cahill P Smallwood KW Yau J Nathans 2003 Structure-function analysis of the bestrophin family of anion channels J Biol Chem 278 41114 41125 10.1074/jbc.M306150200 12907679
11. AD Marmorstein TR Kinnick 2007 Focus on molecules: Bestrophin (Best-1) Exp Eye Res 85 423 424 10.1016/j.exer.2006.03.021 16720022
12. H Sun T Tsunenari KW Yau J Nathans 2002 The vitelliform macular dystrophy protein defines a new family of chloride channels Proc Natl Acad Sci USA 99 4008 4013 10.1073/pnas.052692999 11904445
13. K Yu Y Cui HC Hartzell 2006 The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function Invest Ophthalmol Vis Sci 47 4956 4961 10.1167/iovs.06-0524 17065513
14. HC Hartzell Z Qu K Yu Q Xiao LT Chien 2008 Molecular physiology of bestrophins: multifunctional membrane proteins linked to Best disease and other retinopathies Physiol Rev 88 639 672 10.1152/physrev.00022.2007 18391176
15. AD Marmorstein HE Cross NS Peachey 2009 Functional roles of bestrophins in ocular epithelia Prog Retin Eye Res 28 206 226 10.1016/j.preteyeres.2009.04. 004 19398034
16. F Best 1905 Über eine hereditäre Makulaaffektion Z F Augenheilk 13 199 212
17. AF Deutman 1969 Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state Arch Ophthalmol 81 305 316 5774285
18. HE Cross L Bard 1974 Electro-oculography in Best macular dystrophy Am J Ophthalmol 77 46 50 4824173
19. IV Glybina RN Frank 2006 Localization of multifocal electroretinogram abnormalities to the lesion site: findings in a family with Best disease Arch Ophthalmol 124 1593 1600 10.1001/archopht.124.11.1593 17102007
20. CJF Boon T Theelen EH Hoefsloot MJ van Schooneveld JEE Keunen FPM Cremers BJ Klevering CB Hoyng 2009 Clinical and molecular genetic analysis of Best vitelliform macular dystrophy Retina 29 835 847 10.1097/IAE.0b013e31819d4fda 19357557
21. AB Renner H Tillack H Kraus F Kramer N Mohr BHF Weber MH Foerster U Kellner 2005 Late onset is common in Best macular dystrophy associated with VMD2 gene mutations Ophthalmology 112 586 592 10.1016/j.ophtha.2004.10.041 15808248
22. B Wabbels MN Preising U Kretschmann A Demmler B Lorenz 2006 Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy Graefes Arch Clin Exp Ophthalmol 244 1453 1466 10.1007/s00417-006-0286-6 16612637
23. CJ Boon BJ Klevering AI den Hollander MN Zonneveld T Theelen FPM Cremers CB Hoyng 2007 Clinical and genetic heterogeneity in multifocal vitelliform dystrophy Arch Ophthalmol 125 1100 1106 10.1001/archopht.125.8.1100 17698758
24. CW Mohler SL Fine 1981 Long-term evaluation of patients with Best vitelliform dystrophy Ophthalmology 88 688 692 7267039
25. CJ Boon JB Klevering JE Keunen CB Hoyng T Theelen 2008 Fundus autofluorescence imaging of retinal dystrophies Vis Res 48 2569 2577 10.1016/j.visres.2008.01.010 18289629
26. G Querques M Regenbogen G Soubrane EH Souied 2009 High-resolution spectral domain optical coherence tomography findings in multifocal vitelliform macular dystrophy Surv Ophthalmol 54 311 316 10.1016/j.survophthal.2008.12.010 19298908
27. KG Noble BM Scher RE Carr 1978 Polymorphous presentations in vitelliform macular dystrophy: subretinal neovascularization and central choroidal atrophy Br J Ophthalmol 62 561 570 10.1136/bjo.62.8.561 687557
28. GT Frangieh WR Green SL Fine 1982 A histopathologic study of Best macular dystrophy Arch Ophthalmol 100 1115 1121 7092655
29. S O'Gorman WA Flaherty GA Fishman EL Berson 1988 Histopathologic findings in Best vitelliform macular dystrophy Arch Ophthalmol 106 1261 1268 3415551
30. CF Blodi EM Stone 1990 Best vitelliform dystrophy Ophthalmic Paediatr Genet 11 49 59 2190134
31. GA Fishman W Baca KR Alexander DJ Derlacki AM Glenn M Viana 1993 Visual acuity in patients with Best vitelliform macular dystrophy Ophthalmology 100 1665 1670 8233392
32. MM Chung KT Oh LM Streb AE Kimura EM Stone 2001 Visual outcome following subretinal hemorrhage in Best disease Retina 21 575 580 10.1097/00006982- 200112000-00003 11756879
33. RE Andrade ME Farah JA Cardillo AL Hofling-Lima F Uno RA Costa 2002 Optical coherence tomography in choroidal neovascular membrane associated with Best vitelliform dystrophy Acta Ophthalmol Scand 80 216 218 10.1034/j.1600-0420. 2002.800218.x 11952492
34. RE Andrade ME Farah RA Costa 2003 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Best disease Am J Ophthalmol 136 1179 1181 10.1016/S0002-9394(03)00711-6 14644242
35. J Leu NF Schrage RF Degenring 2007 Choroidal neovascularization secondary to Best disease in a 13-year-old boy treated by intravitreal bevacizumab Graefes Arch Clin Exp Ophthalmol 245 1723 1725 10.1007/s00417-007-0604-7 17605026
36. G Querques MC Bocco G Soubrane EH Souied 2008 Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy Acta Ophthalmol 86 694 695 10.1111/j.1600-0420.2007.01132.x 18752521
37. B Bakall T Marknell S Ingvast MJ Koisti O Sandgren W Li AAB Bergen S Andreasson T Rosenberg K Petrukhin C Wadelius 1999 The mutation spectrum of the bestrophin protein-functional implications Hum Genet 104 383 389 10.1007/s004390050972 10394929
38. F Kramer K White D Pauleikhoff A Gehrig L Passmore A Rivera G Rudolph U Kellner M Andrassi B Lorenz K Rohrschneider A Blankenagel B Jurklies H Schilling F Schutt FG Holz BH Weber 2000 Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult-onset vitelliform macular dystrophy but not age-related macular degeneration Eur J Hum Genet 8 286 292 10.1038/sj.ejhg.5200447 10854112
39. M Brown M Marmor ZE Vaegan M Brigell M Bach ISCEV 2006 ISCEV standard for clinical electro-oculography (EOG) Doc Ophthalmol 113 205 212 10.1007/s10633-006-9030-0 17109157
40. VJ Srinivasan BK Monson M Wojtkowski RA Bilonick I Gorczynska R Chen JS Duker JS Schuman JG Fujimoto 2008 Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography Invest Ophthalmol Vis Sci 49 1571 1579 10.1167/iovs.07-0838 18385077
41. RF Mullins MH Kuehn EA Faidley NA Syed EM Stone 2007 Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease Invest Ophthalmol Vis Sci 48 3372 3380 10.1167/iovs.06-0868 17591911
42. J Deguchi A Yamamoto T Yoshimori K Sugasawa Y Moriyama M Futai T Suzuki K Kato M Uyama Y Tashiro 1994 Acidification of phagosomes and degradation of rod outer segments in rat retinal pigment epithelium Invest Ophthalmol Vis Sci 35 568 579 8113008
43. TJ Jentsch 2007 Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters J Physiol 578 633 640 10.1113/jphysiol.2006. 124719 17110406
44. 2+-channel activation modulate phagocytosis by retinal pigment epithelium Cell Signal 20 1159 1168 10.1016/j.cellsig.2008.02.005 18395422
45. R Rosenthal H Heimann H Agostini G Martin LL Hansen O Strauss 2007 Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease Mol Vis 13 443 456 17417605
46. T Weingeist J Kobrin R Watzke 1982 Histopathology of Best macular dystrophy Arch Ophthalmol 100 1108 1114 7092654
47. RF Mullins KT Oh E Heffron G Hageman EM Stone 2005 Late development of vitelliform lesions and flecks in a patient with Best disease Arch Ophthalmol 123 1588 1594 10.1001/archopht.123.11.1588 16286623
48. B Bakall RA Radu JB Stanton JM Burke BS McKay C Wadelius RF Mullins EM Stone GH Travis AD Marmorstein 2007 Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2) Exp Eye Res 85 34 43 10.1016/j.exer.2007.02.018 17477921
49. MJ Pianta TS Aleman AV Cideciyan JS Sunness Y Li BA Campochiaro PA Campochiaro DJ Zack EM Stone SG Jacobson 2003 In vivo micropathology of Best macular dystrophy with optical coherence tomography Exp Eye Res 76 203 211 10.1016/S0014-4835(02)00280-4 12565808
50. G Men F Batioglu SS Ozkan A Huban Y Ozdamar O Aslan 2004 Best vitelliform macular dystrophy with pseudohypopyon: an optical coherence tomography study Am J Ophthalmol 137 963 965 10.1016/j.ajo.2003.11.014 15126177
51. V Vedantham K Ramasamy 2005 Optical coherence tomography in Best disease: an observational case report Am J Ophthalmol 139 351 353 10.1016/j.ajo.2004.07. 039 15734003
52. RF Spaide K Noble A Morgan KB Freund 2006 Vitelliform macular dystrophy Ophthalmology 113 1392 1400 10.1016/j.ophtha.2006.03.023 16877078
53. RF Spaide 2008 Autofluorescence from the outer retina and subretinal space. Hypothesis and review Retina 28 5 35 10.1097/IAE.0b013e318158eca4 18185134
54. G Querques M Regenbogen C Quijano N Delphin G Soubrane EH Souied 2008 High-definition optical coherence tomography features in vitelliform macular dystrophy Am J Ophthalmol 146 501 507 10.1016/j.ajo.2008.05.029 18619572
55. RJ Zawadzki SM Jones SS Olivier M Zhao BA Bower JA Izatt S Choi S Laut JS Werner 2005 Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in vivo imaging Opt Express 13 8532 8546 10.1364/OPEX.13.008532 19096728
56. FH Verhoeff 1903 A hitherto undescribed membrane of the eye and its significance Boston Med Surg J 149 456
57. S Maia-Lopes ED Silva A Reis MF Silva C Mateus M Castelo-Branco 2008 Retinal function in Best macular dystrophy: relationship between electrophysiological, pychophysical, and structural measures of damage Invest Ophthalmol Vis Sci 49 5553 5560 10.1167/iovs.08-2093 18775865